China

Anew Labs, ByteDance’s AI drug-discovery spin-off, has raised $290 million in its first external round at a valuation of about $1.5 billion.

BEYOND announced on Wednesday that its flagship annual event will return to The Venetian Macao Cotai Expo from May 26-29, 2027, with a refreshed global identity under the BEYOND brand.

Kazakhstan’s venture capital ecosystem is still young, but Askar Bilisbekov, CEO and board member of Alem Capital Management, sees room for growth through more institutional capital, stronger international links and deeper ties with China.

TDCX Hong Kong Managing Director Michael Cowell discusses AI-assisted CX, changing frontline roles, better metrics, data residency and what makes an operation genuinely AI-native.

Hong Kong's first five-year plan sets out AI governance, fintech infrastructure, startup funding and commercialization measures through 2030.

China puts equal emphasis on development and security in artificial intelligence (AI) and has released an updated AI safety governance framework, its foreign ministry said.

GSK agreed to acquire global rights to a Chimagen multiple myeloma program in a deal with an undisclosed upfront fee and contingent payments totaling up to $750 million.

China's AlphaPai, an AI assistant for investment research, has raised $50 million in a Series B round backed by major Chinese financial institutions, its third funding round in a year.

China's foreign ministry warned against "fear-mongering" over AI after U.S. executives, led by Anthropic's Dario Amodei, called for slowing the technology's development and cautioned that a Chinese lead would threaten U.S. security.

Z.AI proposes a Hong Kong share placement and a separate convertible-bond issue with combined gross proceeds of about $5 billion, subject to closing conditions.